TB-500

Overview

TB-500 is a synthetic version of an active region of thymosin beta-4, a small protein the body produces naturally and keeps in nearly every cell at high concentrations. Thymosin beta-4 is one of the most abundant actin binding proteins in human tissue, which is a clue to how central its job is. TB-500 reproduces the part of that protein most associated with tissue repair, which is why it is studied as a companion to BPC-157 in the healing and recovery category. The two are often examined and used together in research because they act on different parts of the same repair sequence. It appears in The Wolverine, The Glow, The KLOW, and the flagship kit.

How it works

Its central mechanism involves actin, the protein that forms the internal scaffolding cells use to hold their shape and to move. TB-500 helps manage the supply of building block actin, which cells draw on when they need to assemble that scaffolding quickly and migrate. Cell migration is one of the earliest steps in wound healing, since the cells that rebuild skin, the cells that lay down tissue, and the cells that line blood vessels all need to move into a wounded area. Research also describes TB-500 supporting the growth of new blood vessels, helping shift inflammatory cells from an aggravating state to a resolving one, and protecting cells under stress. These overlapping actions are why it is often described as influencing several phases of healing at once rather than a single step.

What researchers study

In preclinical models, researchers examine TB-500 for cell migration, blood vessel formation, reduced inflammation, and cell survival across tissues that include skin, cornea, heart, and the nervous system. Some of the strongest mechanistic work centers on the heart, where thymosin beta-4 is studied for mobilizing repair cells after injury. A recent scoping review mapped this literature and found that the human evidence is concentrated in eye and wound healing settings, while direct musculoskeletal evidence is thinner and largely preclinical. As with BPC-157, the underlying actin biology is well established across several independent laboratories, but the tissue repair findings rest mostly on cell and animal studies rather than large human trials. That distinction is worth keeping in view when reading the research.

Published references

• Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review
• Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review

Research Use Only. Not for human or animal use.